Update on secondary listing on the JSE

Primary Health Properties PLC
17 October 2023
 

17 October 2023

 

Primary Health Properties PLC

("PHP", the "Company" or the "Group")

 

Update on secondary listing on the Johannesburg Stock Exchange

 

Primary Health Properties plc (LSE: PHP), one of the UK's leading investors in modern primary healthcare facilities, is pleased, following the announcement on 6 September 2023, to confirm the release of a pre-listing announcement ("PLA") relating to a secondary inward listing on the Main Board of the Johannesburg Stock Exchange ("JSE"). The listing of PHP on the JSE is expected to become effective on 24 October 2023.

 

The Company will not place or issue any new PHP shares in connection with its application for a secondary listing on the JSE and will remain listed on the premium segment of the Official List in London. PSG Capital Proprietary Limited have been appointed as Corporate Advisor and Sponsor on the JSE.

 

PHP believes that admission to trading on the JSE will be beneficial to the Company and its stakeholders. The Board of PHP believes that the secondary listing can be expected to contribute to liquidity in the Group's shares through its increased profile in the South African market, where a number of investors have already shown strong interest in investing in PHP, driven by its high-quality, government-backed income stream and robust operating model.

 

More information on Primary Health Properties PLC can be found on www.phpgroup.co.uk

 

Further details:

 

Harry Hyman

Chief Executive Officer

Tel: +44 (0) 7973 344768

Richard Howell

Chief Financial Officer

Tel: +44 (0) 7766 072272

 

David Rydell / Stephanie Whitmore / Hannah Ratcliff / Verity Parker
(Buchanan Communications)

Tel: +44 (0) 20 7466 5000



 



 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings